Literature DB >> 6206166

Monoclonal antibody 4F2 reactive with basal layer keratinocytes: studies in the normal and a hyperproliferative state.

J A Patterson, M Eisinger, B F Haynes, C L Berger, R L Edelson.   

Abstract

To establish a method for separating different keratinocyte subpopulations in the epidermis, we studied the specificity of monoclonal antibody 4F2 for keratinocytes. Preliminary screening experiments had previously demonstrated 4F2 reactivity with the epidermis. 4F2 reacted with a subpopulation (19.29 +/- 5.23%) of human epidermal cells in suspension. The membrane antigen identified by 4F2 continues to be expressed by cultured keratinocytes. In frozen tissue section using an indirect immunofluorescence technique, the 4F2-positive cells in the basal layer are sharply demarcated from the negative suprabasilar layers. Even in the hyperproliferative state of psoriasis, the 4F2 reactivity is confined to the basal layer. Cell suspensions of psoriatic epidermis demonstrated a greater percentage of reactivity with 4F2 (49.51% +/- 6.50%), probably reflecting the expanded population of basal layer cells. Monoclonal 4F2, therefore, reacts with a membrane antigen present on basal keratinocytes, and provides a probe for use in the isolation of the basal keratinocyte subpopulation. Thus, this antibody should be useful in studies of normal and aberrant differentiation of the epidermis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206166     DOI: 10.1111/1523-1747.ep12263581

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  Cell size as a determinant of the clone-forming ability of human keratinocytes.

Authors:  Y Barrandon; H Green
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

2.  Dolichos biflorus agglutinin (DBA) reveals a similar basal cell differentiation in normal and psoriatic epidermis.

Authors:  A L Kariniemi; I Virtanen
Journal:  Histochemistry       Date:  1989

Review 3.  CD98 at the crossroads of adaptive immunity and cancer.

Authors:  Joseph M Cantor; Mark H Ginsberg
Journal:  J Cell Sci       Date:  2012-04-12       Impact factor: 5.285

4.  Cloning, sequence analysis, and expression of the large subunit of the human lymphocyte activation antigen 4F2.

Authors:  J A Lumadue; A B Glick; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  CD98hc (SLC3A2) regulation of skin homeostasis wanes with age.

Authors:  Etienne Boulter; Soline Estrach; Aurélia Errante; Catherine Pons; Laurence Cailleteau; Floriane Tissot; Guerrino Meneguzzi; Chloé C Féral
Journal:  J Exp Med       Date:  2013-01-07       Impact factor: 14.307

6.  Beta1 integrins show specific association with CD98 protein in low density membranes.

Authors:  T V Kolesnikova; B A Mannion; F Berditchevski; M E Hemler
Journal:  BMC Biochem       Date:  2001-10-15       Impact factor: 4.059

7.  Phage display cloning and characterization of monoclonal antibody genes and recombinant Fab fragment against the CD98 oncoprotein.

Authors:  K Itoh; K Inoue; K Hirooka; K Maruyama; M Ohkawa; K Matsui; H Tada; T Enomoto; Y Hashimoto; T Suzuki; T Masuko
Journal:  Jpn J Cancer Res       Date:  2001-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.